Ind-Swift Laboratories Balance Sheet Annual

Trade

BSE: 532305 | NSE: INDSWFTLAB | ISIN: INE915B01019 | Sector: Major Drugs

99.85 -2.00 (-1.96%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	431.93	0.00	-	0.00
Short Term Investments	0.00	36.98	59.12	64.09
Cashand Short Term Investments	431.93	45.02	70.41	65.57
Accounts Receivable- Trade Net	169.12	505.47	454.94	432.56
Total Receivables Net	169.12	669.97	564.45	492.16
Total Inventory	10.46	438.60	428.50	375.67
Other Current Assets Total	49.62	1.91	2.39	4.54
Total Current Assets	661.13	1,164.52	1,075.33	944.18
Property/ Plant/ Equipment Total- Net	5.36	592.75	636.84	748.09
Intangibles Net	0.00	0.00	1.00	9.20
Long Term Investments	113.32	35.98	34.68	56.41
Other Long Term Assets Total	385.29	30.82	52.95	60.36
Total Assets	1,165.11	1,824.06	1,800.79	1,818.45
Accounts Payable	93.98	203.99	175.95	138.82
Current Portof LT Debt/ Capital Leases	5.46	108.97	104.73	0.03
Other Currentliabilities Total	121.84	58.12	53.79	54.96
Total Current Liabilities	221.28	371.09	334.47	314.52
Long Term Debt	11.16	752.60	847.78	884.13
Capital Lease Obligations	0.00	0.53	0.51	0.48
Total Long Term Debt	11.16	753.13	848.29	884.61
Total Debt	16.62	862.10	953.02	1,005.35
Minority Interest	-0.02	0.00	-0.11	-0.09
Other Liabilities Total	1.23	17.91	17.18	15.90
Total Liabilities	233.65	1,142.13	1,199.82	1,214.94
Common Stock Total	59.09	59.81	59.81	59.81
Retained Earnings( Accumulated Deficit)	872.37	133.83	40.10	27.95
Other Equity Total	0.00	-2.42	-2.74	-2.31
Total Equity	931.46	681.93	600.97	603.51
Total Liabilities Shareholders' Equity	1,165.11	1,824.06	1,800.79	1,818.45
Total Common Shares Outstanding	5.91	5.91	5.91	5.91
Tangible Book Valueper Share Common Eq	157.64	115.41	101.54	100.55
Cash	-	8.03	11.30	1.48
Prepaid Expenses	-	9.02	9.58	6.24
Property/ Plant/ Equipment Total- Gross	-	1,338.61	11.18	1,311.47
Accumulated Depreciation Total	-	-745.86	-	-563.38
Notes Payable/ Short Term Debt	-	0.00	0.00	120.72
Additional Paid- In Capital	-	307.31	307.31	307.31
Unrealized Gain( Loss)	-	183.41	196.49	210.75
Goodwill Net	-	-	-	0.21
Note Receivable- Long Term	-	-	-	0.00